Pellef.com

View the Pharmaceutical Commerce August 2025 issue in an interactive format.

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation.I’m your host, and today we’re covering three key developments—from major manufacturing investments to a shake-up in pharmacy customer satisfaction rankings, and shifting insurance coverage for GLP-1 drugs. AbbVie has […]

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using AI to replicate authentic pharmaceutical packaging with high accuracy, build convincing fake websites, and manipulate […]

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re looking at three stories shaping the intersection of pharmaceutical business, healthcare delivery, and patient safety. Cardinal Health has announced plans to acquire Solaris Health, […]

In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff is applied. If imposed on active pharmaceutical ingredients (APIs), the impact would be minimal, as […]

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering leadership changes at the FDA, new research on COVID-19 risks for childhood cancer survivors, and strategies pharma companies are using to stay […]

Image Credit: Adobe Stock Images/DavideBonaldo.com Last week, President Trump issued letters to 17 of the largest pharmaceutical companies, expressing dire urgency for making changes along the drug pricing front.1 These letters date back to an executive order (EO) he enacted in May that essentially proclaimed that pharma companies need to treat the United States as a […]

In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence prescription drug spending by reshaping access and reimbursement within Medicaid, certain Medicare segments, and ACA exchange plans. The OBBBA introduces pressure on pharmaceutical revenues, particularly by […]

Image Credit: Adobe Stock Images/Ibnu.com Novo Nordisk recently filed 14 new lawsuits intended to protect patients from unapproved compounded drugs that falsely claim to contain semaglutide. The defendants that are mentioned in the lawsuits claim that these compounded products have been both reviewed and approved by the FDA, or are just as effective as manufacturer’s […]

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This “last mile” delivery is essential because, as Zenk notes, “all healthcare is local.” Patients want […]

Image Credit: Adobe Stock Images/Ishika.com Noom, an online weight loss company, is unveiling its Microdose GLP-1Rx Program, a service intended to limit side effects via personalized microdoses of GLP-1s, when clinically appropriate of course.1 The initial price of the program is $119 to start, and $199 per month for a maximum 0.6-milligram dose thereafter. The prices […]

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This “last mile” delivery is essential because, as Zenk notes, “all healthcare is local.” Patients want […]

Image Credit: Adobe Stock Images/JozefMicic.com Esteve has purchased Regis Technologies, a Chicago-based contract development and manufacturing organization (CDMO), for an undisclosed amount.1 The deal provides Esteve CDMO—a Spain-based, third-party CDMO that operates under the Esteve Química brand—the opportunity to have a physical presence in the United States, a country where the company has been looking to […]

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This “last mile” delivery is essential because, as Zenk notes, “all healthcare is […]

What Clinical Ops Teams Must Know About Biomarkers in Trials In an interview with Applied Clinical Trials, Michael Miller, COO of Quanterix, emphasized that clinical operations teams must carefully consider the purpose, technical requirements, and regulatory implications of biomarkers in trials—especially as their use expands in neurology, oncology, and platform studies driving accelerated drug approvals. […]

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This “last mile” delivery is essential because, as Zenk notes, “all healthcare is […]